Trade ROIV anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Roivant Sciences Ltd. Common Shares (ROIV) is trading at US$35.72, down 4.95% today as of Aug 28, 12:33 EDT. The company has a market capitalisation of US$26.22B. Over the past 52 weeks, ROIV has traded between US$11.85 and US$37.97. On Syfe you can trade ROIV with $0 commission and add it to your watchlist.
| Previous close | US$37.58 |
|---|---|
| Market cap | US$26.22B |
| 52-week range | US$11.85 – US$37.97 |
| Volume | 4.92M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Roivant Sciences Ltd. Common Shares
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Year: 2021
Stay on top of ROIV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
